| 1 |
Menninger L, Körner A, Mirakaj V, Heck-Swain KL, Haeberle HA, Althaus K, Baumgaertner M, Jost W, Schlensak C, Rosenberger P, Koeppen M. Membrane oxygenator longevity was higher in argatroban-treated patients undergoing vvECMO. Eur J Clin Invest 2023;:e13963. [PMID: 36718989 DOI: 10.1111/eci.13963] [Reference Citation Analysis]
|
| 2 |
Bachler M, Asmis LM, Koscielny J, Lang T, Nowak H, Paulus P, Schewe JC, von Heymann C, Fries D. Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review. Blood Coagul Fibrinolysis 2022. [PMID: 35703225 DOI: 10.1097/MBC.0000000000001133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Dukhin OA, Kalinsaya AI, Shpektor AV, Vasilieva EY. The role of thrombin in the pathogenesis of atherosclerosis and its complications. Kardiologiia 2022;62:73-81. [DOI: 10.18087/cardio.2022.3.n1968] [Reference Citation Analysis]
|
| 4 |
Marchetti M, Barelli S, Gleich T, Gomez FJ, Goodyer M, Grandoni F, Alberio L. Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia. Br J Haematol 2022. [PMID: 35358358 DOI: 10.1111/bjh.18120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Berlot G, Tomasini A, La Fata C, Pintacuda S, Rigutti S, Falanga A, Doganay M. Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination. Case Reports in Critical Care 2022;2022:1-4. [DOI: 10.1155/2022/6804456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Benavides TM, Hulsizer AL. Drugs that affect blood coagulation, fibrinolysis and hemostasis. Side Effects of Drugs Annual 2022. [DOI: 10.1016/bs.seda.2022.09.011] [Reference Citation Analysis]
|
| 7 |
Sun S, Urbanus RT, ten Cate H, de Groot PG, de Laat B, Heemskerk JWM, Roest M. Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia. Cells 2021;10:3386. [DOI: 10.3390/cells10123386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 8 |
FACME multidisciplinary working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021;36:451-61. [PMID: 34112621 DOI: 10.1016/j.nrleng.2021.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Grupo de trabajo multidisciplinar de FACME sobre el manejo de la trombosis venosa cerebral relacionada con la vacunación frente a COVID-19. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia 2021:S0213-4853(21)00083-9. [PMID: 34049738 DOI: 10.1016/j.nrl.2021.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
